Dr. Shi of EdgeTech Law: Despite Mayo Clinic v. Prometheus “Setback,” Opportunities in Life Sciences Remain

OneMedPlace is pleased to announce a special interview series exploring current issues facing the diagnostics sector and life sciences.

Read more »

Biovest CEO and Sr. Vice President Discuss Global Marketing of BiovaxID

Biovest International, Inc. (OTCQB: BVTI) announced that Biovest is seeking marketing approval in Canada for BiovaxID®, its personalized cancer vaccine for the treatment of follicular non-Hodgkin’s lymphoma.

Read more »

NeuroMetrix Files 510(k) for SENSUS(TM) Pain Therapy Device

NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes has filed a 510(k), with the FDA for its SENSUS Pain Therapy device.

Read more »

Complete Genomics Well Positioned to Move from Research to Clinical in Genome Sequencing

OneMedRadio recently conducted an interview with Dr. Clifford A. Reid, the company’s President and Chief Executive Officer.

Read more »

Epigenomics Enrolls First Participant in its FIT Comparative Study with Epi proColon®

OneMedRadio interviewed Thomas Taapken, CFO of Epigenomics, a Berlin based molecular diagnostics company for the early detection of cancer.

Read more »

AVI Biopharma’s Chief Science Officer To Resign

Drug developer AVI Biopharma Inc. said Thursday that Chief Scientific Officer Peter Linsley will resign from the company.

Read more »

PTSD Special Report, Part II: Promising Treatments and Emerging Opportunities

This is Part II of our special report on PTSD, a survey of the rising causes for concern and potential treatments to combat it.

Read more »

Advaxis Receives Best Therapeutic Vaccine Award

The 5th Annual Vaccine Industry Excellence Awards has named Advaxis as the Best Therapeutic Vaccine for the company’s ADVX-HPV construct.

Read more »

PTSD Special Report: Part I, How to Curb a Potential Epidemic

In response to a recent press release from TONIX Pharmaceuticals, a leading company in the exploration of alternative PTSD treatment, we are issuing a 2-part special report looking at recent developments

Read more »

March/April 2012

The OneMedResearch March/April 2012 Issue continues the discussion of 10 small companies with intriguing technology in an emerging market.  This issue focuses its […]

Read more »